SC questions Centre’s delay in regulating cancer drug margins, reserves verdict on medicine pricing
New Delhi, Oct 27 (IANS) The Supreme Court on Tuesday questioned the Centre over its decision to cap trade margins on anti-cancer medicines at 30 per cent, asking why the government had taken so long to act on the issue and expressing…
Read More...
Read More...